glp 1 announcement President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco breaks it down on the latest GLP-1 Weight-Loss Drug Demonstration Begins

For symptom management of neuropathic pain, the American Academy of Neurology and American Diabetes Association guidelines recommend: First-line: Duloxetine or pregabalin (with appropriate renal dose adjustments) Alternative options: Gabapentin (with renal dose adjustments) or tricyclic antidepressants (with caution in older adults and cardiac disease) Topical treatments: Capsaicin 8% patch or lidocaine 5% patch for localized symptoms Avoid chronic opioid therapy due to limited evidence and safety concerns Non-pharmacological approaches including physical therapy, proper foot care, and pain psychology techniques provide additional benefit

However, supplements that support energy production and stress resilience are often recommended

But with practice, it can become part of your medication regimen without fear or problems

3.3.3 Resistin Resistin serves as a protein-based hormone intricately involved in processes like insulin resistance and conditions linked to obesity

Choose it if your skin tends to feel tight, or pair it with the serum for the full treat-then-seal routine

Figure 3 + ) neurons